| Prev Close | 58.00 |
| Open | 57.97 |
| Day Low/High | 57.96 / 57.99 |
| 52 Wk Low/High | 25.02 / 87.38 |
| Volume | 249.29K |
| Avg Volume | 563.70K |
| Exchange | |
| Shares Outstanding | 17.56M |
| Market Cap | 1.02B |
| EPS | -4.20 |
| Div & Yield | N.A. (N.A) |
HeartWare (HTWR) stock rating was cut to ‘equal weight’ from ‘overweight’ at Barclays on Wednesday morning.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
HeartWare (HTWR) stock is skyrocketing Monday afternoon after the medical device company agreed to be acquired by Medtronic (MDT) for about $1.1 billion.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of HeartWare...
Engaged Capital agitated against the cardiac medical device maker's buy of an Israeli company and pushed for a new board member that once led the acquirer's M&A efforts.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Medtronic's $1.1 billion proposed acquisition of HeartWare International on Monday is a smart deal.
TheStreet highlights 3 stocks pushing the health care sector higher today.
U.S. stocks extended their declines, piling on heavy losses suffered at the end of last week, as markets continued to react to the pro-exit vote from the U.K.
Stock losses accelerate by late morning Monday as the fallout from Friday's 'Brexit' vote punishes global markets.
HeartWare (HTWR) stock is soaring on Monday morning after the company agreed to be bought by Medtronic (MDT) for about $1.1 billion.
Medtronic started its drive after buying Covidien and switching its tax base to Ireland. Now it's buying Heartware International, Cramer says.
Stock futures point to another day in the red on Monday, piling on heavy losses suffered at the end of last week.
Trade-Ideas LLC identified Heartware International (HTWR) as a pre-market mover with heavy volume candidate
Trade-Ideas LLC identified Heartware International (HTWR) as a "perilous reversal" (up big yesterday but down big today) candidate
Investors eyeing a purchase of Heartware International Inc shares, but cautious about paying the going market price of $35.70/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $17.50 strike, which has a bid at the time of this writing of $1.20.
Glen Welling's Engaged Capital has targeted Outerwall, Heartware, Magnachip, Jamba Juice and Benchmark Electronics. Here's his plans for each company.
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming March 22, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class") of investors who...
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of HeartWare International, Inc.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased HeartWare International, Inc.
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
Trade-Ideas LLC identified Heartware International (HTWR) as a "dead cat bounce" (down big yesterday but up big today) candidate
Stocks with insider trader activity include JAKK, HTWR and SMCI
Trade-Ideas LLC identified Heartware International (HTWR) as a "dead cat bounce" (down big yesterday but up big today) candidate
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...
The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased...
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased HeartWare International, Inc.
